期刊文献+

扶正胶囊改善安罗替尼治疗相关癌因性疲乏临床研究

Clinical Research of Fuzheng Capsule Improving Cancer-Related Fatigue Induced by Anlotinib
下载PDF
导出
摘要 目的:观察扶正胶囊改善安罗替尼治疗所致癌因性疲乏的临床疗效。方法:选取满足标准的50例患者,随机分为对照组和治疗组,每组各25例,治疗组在对照组基础上加用扶正胶囊,连续观察2疗程(共计6周)。结果:治疗组改善疲乏症状及减轻临床症状疗效更佳(P<0.05)。治疗组相较于对照组能够在一定程度上提高患者的KPS评分,提高生活质量(P<0.05);治疗组较对照组在CD3^(+)、CD4^(+)、CD4^(+)/CD8^(+)的改善方面更优(P<0.05)。对照组及治疗组患者的肝肾功能在治疗前后差异均无统计学意义,说明药物安全性高(P>0.05)。结论:扶正胶囊对患者疲乏等级的降低更有疗效;能减轻患者的中医证候及功能状态;能增加患者的机体免疫能力,且不良反应少,使用安全性高,值得临床推广及进一步研究。 Objective:To observe the clinical curative effect of Fuzheng capsule in improving cancer-related fatigue caused by Anlotinib Hydrochloride.Methods:In this study,50 patients who conformed to the inclusion and exclusion criteria were divided into the control group and the treatment group randomly,with 25 cases in each group.Fuzheng capsule was added to the treatment group on the basis of the control group.Two courses of treatment were observed consecutively(6 weeks).Results:In terms of improving fatigue symptoms and relieving clinical symptoms,the treatment group had better efficacy(P<0.05).In terms of improving the quality of life,compared with the control group,the treatment group could improve the patients'KPS score and the quality of life to a certain extent(P<0.05).In terms of CD immune cell test,the treatment group was better in the improvement of CD3^(+),CD4^(+)and CD4^(+)/CD8^(+)than the control group(P<0.05).In terms of safety indexes,there were no significant differences in liver function and renal function between the control group and the treatment group before and after treatment,indicating high safety(P>0.05).Conclusion:In terms of fatigue symptoms,it was more effective to reduce the fatigue level of patients;In terms of TCM symptoms and functional state,it can reduce the clinical symptoms of patients and improve the functional state of patients;In terms of immune status,the immune capacity of patients can be increased;In terms of drug safety,there are few adverse reactions and high safety,which is worthy of clinical promotion and further study.
作者 邱陈健 高静东 陆程洁 顾珈裔 Qiu Chenjian;Gao Jingdong;Lu Chengjie;Gu Jiayi(Suzhou Ninth People's Hospital,Suzhou 215200,China;Suzhou Hospital of Traditional Chinese Medicine,Suzhou 215200,China;Changshu No.2 People's Hospital,Suzhou 215200,China)
出处 《亚太传统医药》 2023年第9期125-130,共6页 Asia-Pacific Traditional Medicine
关键词 扶正胶囊 癌因性疲乏 安罗替尼 临床研究 Fuzheng Capsule Cancer-Related Fatigue Anlotinib Clinical Research
  • 相关文献

参考文献7

二级参考文献65

  • 1申利红,王建森,李雅,张大海,朱廷春.植物多糖的研究及应用进展[J].中国农学通报,2011,27(2):349-352. 被引量:158
  • 2陈军辉,谢明勇,易秀琴,张中伟,聂少平.西洋参多糖提取新工艺研究[J].时珍国医国药,2005,16(10):977-979. 被引量:16
  • 3刘成军,韦世秀,李牡艳,李佳荃.黄芪注射液对人鼻咽癌CNE-2细胞株的抑制作用研究[J].中国药房,2005,16(18):1376-1378. 被引量:25
  • 4Gupta D, Lis CG, Grutsch JF. The relationship between cancer-re- lated fatigue and patient satisfaction with quality of life in cancer [ J]. J Pain Symptom Manage, 2007, 34( 1 ) : 40 - 47.
  • 5Wang XS, Hao XS, Wang Y, et al. Validation study of the Chinese version of the Brief Fatigue Inventory (BFI-C) [J]. J Pain Symp- tom Manage, 2004, 27(4) : 322 - 332.
  • 6Okuyama T, Akechi T, Kugaya A, et al. Development and valida- tion of the cancer fatigue scale: A brief, three-dimensional, self-rat- ing scale for assessment of fatigue in cancer patients [ J]. J Pain Symptom Manage, 2000, 19( 1 ) : 5 - 14.
  • 7Shun SC, Beck SL, Pett M A, et al. Psychometric testing of three Chinese fatigue instruments in Taiwan [ J]. J Pain Symptom Man-age, 2006,32(2): 155 - 167.
  • 8Kroz M, Zerm R, Reif M, et al. Validation of the German version of the Cancer Fatigue Scale (CFS-D) [J]. Euro J Cancer Care, 2008, 17(1): 33 -41.
  • 9Beaton DE, Bombardier C, Guillemin F, et al. Guidelines for the process of cross-cultural adaptation of self-report measures I J]. Spine, 2000, 25 (24) : 3186 - 3191.
  • 10Morrow GR, Shelke AR, Roscoe JA, et al. Management of cancer- related fatigue [J]. Cancer Invest, 2005, 23(3) : 229 -239.

共引文献364

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部